These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 25482950)
1. Targeting of two aspects of metabolism in breast cancer treatment. Gang BP; Dilda PJ; Hogg PJ; Blackburn AC Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950 [TBL] [Abstract][Full Text] [Related]
2. Dual-targeting of aberrant glucose metabolism in glioblastoma. Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202 [TBL] [Abstract][Full Text] [Related]
3. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer. Roh JL; Park JY; Kim EH; Jang HJ; Kwon M Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904 [TBL] [Abstract][Full Text] [Related]
4. Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells. Haugrud AB; Zhuang Y; Coppock JD; Miskimins WK Breast Cancer Res Treat; 2014 Oct; 147(3):539-50. PubMed ID: 25212175 [TBL] [Abstract][Full Text] [Related]
5. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase. Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571 [TBL] [Abstract][Full Text] [Related]
6. Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells. Sun RC; Board PG; Blackburn AC Mol Cancer; 2011 Nov; 10():142. PubMed ID: 22093145 [TBL] [Abstract][Full Text] [Related]
7. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC. Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281 [TBL] [Abstract][Full Text] [Related]
8. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis. Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226 [TBL] [Abstract][Full Text] [Related]
9. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells. Choi YW; Lim IK Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191 [TBL] [Abstract][Full Text] [Related]
10. Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells. Decollogne S; Joshi S; Chung SA; Luk PP; Yeo RX; Nixdorf S; Fedier A; Heinzelmann-Schwarz V; Hogg PJ; Dilda PJ Gynecol Oncol; 2015 Aug; 138(2):363-71. PubMed ID: 26080289 [TBL] [Abstract][Full Text] [Related]
11. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation. Kumar A; Kant S; Singh SM Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182 [TBL] [Abstract][Full Text] [Related]
12. Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells. de Mey S; Dufait I; Jiang H; Corbet C; Wang H; Van De Gucht M; Kerkhove L; Law KL; Vandenplas H; Gevaert T; Feron O; De Ridder M Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33316932 [TBL] [Abstract][Full Text] [Related]
13. Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate. Yang J; Cao Q; Zhang H; Hao L; Zhou D; Gan Z; Li Z; Tong YX; Ji LN; Mao ZW Biomaterials; 2018 Sep; 176():94-105. PubMed ID: 29870900 [TBL] [Abstract][Full Text] [Related]
14. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines. Tataranni T; Agriesti F; Pacelli C; Ruggieri V; Laurenzana I; Mazzoccoli C; Sala GD; Panebianco C; Pazienza V; Capitanio N; Piccoli C Cells; 2019 May; 8(5):. PubMed ID: 31109089 [TBL] [Abstract][Full Text] [Related]
15. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment. Ruggieri V; Agriesti F; Scrima R; Laurenzana I; Perrone D; Tataranni T; Mazzoccoli C; Lo Muzio L; Capitanio N; Piccoli C Oncotarget; 2015 Jan; 6(2):1217-30. PubMed ID: 25544754 [TBL] [Abstract][Full Text] [Related]
16. Direct Polymerization of the Arsenic Drug PENAO to Obtain Nanoparticles with High Thiol-Reactivity and Anti-Cancer Efficiency. Noy JM; Lu H; Hogg PJ; Yang JL; Stenzel M Bioconjug Chem; 2018 Feb; 29(2):546-558. PubMed ID: 29346731 [TBL] [Abstract][Full Text] [Related]
17. Synergistic anticancer potential of dichloroacetate and estradiol analogue exerting their effect via ROS-JNK-Bcl-2-mediated signalling pathways. Stander XX; Stander BA; Joubert AM Cell Physiol Biochem; 2015; 35(4):1499-526. PubMed ID: 25791820 [TBL] [Abstract][Full Text] [Related]
18. A potent tumoricidal co-drug 'Bet-CA'--an ester derivative of betulinic acid and dichloroacetate selectively and synergistically kills cancer cells. Saha S; Ghosh M; Dutta SK Sci Rep; 2015 Jan; 5():7762. PubMed ID: 25585916 [TBL] [Abstract][Full Text] [Related]
19. Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α. Škorja Milić N; Dolinar K; Miš K; Matkovič U; Bizjak M; Pavlin M; Podbregar M; Pirkmajer S Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445316 [TBL] [Abstract][Full Text] [Related]